Investment Summary

Mitsubishi Chemical Invests In Mitsubishi Tanabe Pharma

On November 18, 2019, Mitsubishi Chemical invested in life science company Mitsubishi Tanabe Pharma

Investment Highlights
  • This is Mitsubishi Chemical’s 2nd transaction in the Life Science sector.
  • This is Mitsubishi Chemical’s 1st transaction in Japan.

Investment Summary
Date 2019-11-18
Target Mitsubishi Tanabe Pharma
Sector Life Science
Investor(s) Mitsubishi Chemical
Deal Type Stake Purchase

Target

Mitsubishi Tanabe Pharma

Osaka, Japan
Mitsubishi Tanabe Pharma is a research-driven pharmaceutical company that specializes in the research, development, and marketing of globally competitive pharmaceutical products focused on the field of autoimmune disease, diabetes and kidney disease, and CNS disease. Mitsubishi Tanabe Pharma was founded in 1933 and is based in Osaka, Japan.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Mitsubishi Chemical

Tokyo, Japan
Category Company
Founded 2005
Sector Chemicals
Employees66,358
Revenue 4.39T JPY (2024)
DESCRIPTION

Mitsubishi Chemical provides chemistry-based technology platforms for the development of a wide range of technologies and products in the fields of performance products, healthcare, and industrial materials. Mitsubishi Chemical was founded in 2005 and is based in Tokyo, Japan.

DEAL STATS #
Overall 4 of 4
Sector (Life Science) 2 of 2
Type (Stake Purchase) 1 of 1
Country (Japan) 1 of 1
Year (2019) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-21 Cleanpart

Asperg, Germany

Cleanpart GmbH is an industrial services company for the semiconductor industry and related industries. Cleanpart was founded in 1998 and is based in Asperg, Germany.

Buy -
Mergr

Product

Company

Legal